Picture of Green Cross Holdings logo

005250 Green Cross Holdings Share Price

0.000.00%
kr flag iconLast trade - 00:00
HealthcareAdventurousSmall CapValue Trap

Momentum

Relative Strength (%)
1m-5.59%
3m-20.45%
6m-39.08%
1yr-39.8%
Volume Change (%)
10d/3m+317.06%
Price vs... (%)
52w High-16.44%
50d MA+7.04%
200d MA-2.08%

Growth & Value

Shareholder Activity

TypeBuy / Hold / Sell
Institutions
Directors
Community

Guru Screens

Quality

NameIndustryMarket
Return on Capital-0.75%
Return on Equity-7.34%
Operating Margin-0.76%

Financial Summary

Year End 31st DecUnit202120222023202420252026E2027ECAGR / Avg
Total RevenueKR₩m1,840,558.62,079,559.972,057,935.72,204,855.222,451,476.28n/an/a7.35%
Operating Profitm
Net Profitm
EPS Reported
Diluted Normalised EPS
EPS Growth%-36.45-83.8n/an/an/an/an/an/a
PE Ratiox
PEG
Profitability
Operating Margin%
ROA%
ROCE%
ROE%
Cashflow
Op. Cashflow ps
Capex ps
Free Cashflow ps
Dividends
Dividend ps
Dividend Growth%
Dividend Yield%
Dividend Coverx
Balance Sheet
Cash etcm
Working Capitalm
NFAm
Net Debtm
Book Valuem
Diluted Weighted Average Sharesm
Book Value ps

Health Trend(F-Score)

12345678910

Bankruptcy Score(Z-Score)

Distress
Cautious
Safe

Earnings Manipulation Risk(M-Score)

Other Ratios

Leverage (ttm)Total- Intang+ Pension
Gross Gearing
Net Gearing
Cash / Assets

Recent History

Latest interim period vs. prior periodIndustryMarket
Sales Growth
EPS Growth
3yr Compound Annual Growth RateIndustryMarket
Sales CAGR
EPS CAGR
DPS CAGR

Graphical History

Revenue
Blurred out image of Revenue chart
Net Income
Blurred out image of Net Income chart
Normalised EPS
Blurred out image of Normalised EPS chart
PE Ratio Range
Blurred out image of PE Ratio Range chart
Dividend Yield Range
Blurred out image of Dividend Yield Range chart

Analyst Forecasts

Price target
( price)
31st Dec 202631st Dec 2027
Est. Long Term Growth Rate: Net Profit
()
EPS
()
DPS
()
Net Profit
()
EPS
()
DPS
()
Consensus Estimate
1m Change
3m Change

Analyst Consensus

Strong SellSellHoldBuyStrong Buy

EPS 2026 / 2027

Blurred out image of Green Cross Holdings EPS forecast chart

Profile Summary

Green Cross Holdings is a Korea-based holding company principally engaged in the manufacture and distribution of pharmaceuticals. The Company operates its business through five segments. The Pharmaceutical Manufacturing and Sale segment mainly manufactures and sells blood products, general pharmaceuticals, vaccines and over-the-counter (OTC) drugs. The Medical Service and System Development and Supply segment primarily provides healthcare services. The Diagnostic and Analysis segment mainly engages in blood diagnostics and genetic analysis business. The Leasing and Service Business segment is primarily involved in the real estate leasing and the management of affiliated group companies. The Other segment mainly operates livestock operation and other business.

Directors

Last Annual
December 31st, 2025
Last Interim
December 31st, 2025
Incorporated
October 5th, 1967
Public Since
August 28th, 1978
No. of Shareholders
26,225
No. of Employees
170
Sector
Pharmaceuticals
Industry
Healthcare
Exchange
kr flag iconKorea Exchange - KSE
Shares in Issue
45,441,076

005250 Share Price Performance

Similar to 005250

Picture of Aprogen Biologics logo

Aprogen Biologics

kr flag iconKorea Exchange - KSE

Picture of Bionote logo

Bionote

kr flag iconKorea Exchange - KSE

Picture of Boryung logo

Boryung

kr flag iconKorea Exchange - KSE

Picture of Bukwang Pharm Co logo

Bukwang Pharm Co

kr flag iconKorea Exchange - KSE

Picture of Chong Kun Dang Pharmaceutical logo

Chong Kun Dang Pharmaceutical

kr flag iconKorea Exchange - KSE

FAQ